Inflammation: A role for NR4A orphan nuclear receptors?

Biochemical Society Transactions

Volumn 39, Issue 2, 2011, Pages 688-693

  McMorrow, Jason P ^a   Murphy, Evelyn P ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Acute inflammation; Angiogenesis; Chronic inflammation; Cytokine; Macrophage polarization; Nuclear receptor

Indexed keywords

DEXAMETHASONE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; MERCAPTOPURINE; METHOTREXATE; NUCLEAR RECEPTOR NR4A3; NUCLEAR RECEPTOR NUR77; NUCLEAR RECEPTOR RELATED FACTOR 1; PROSTAGLANDIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ATHEROSCLEROSIS; B LYMPHOCYTE; CANCER CELL; CELL ACTIVATION; CELL MIGRATION; CELL POLARITY; COLORECTAL CANCER; CYTOKINE PRODUCTION; FIBROBLAST LIKE SYNOVIOCYTE; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; LUNG CANCER; MACROPHAGE; MODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVIUM; T LYMPHOCYTE; TH1 CELL; TH2 CELL; TRANSCRIPTION REGULATION;

ANIMALS; CELL POLARITY; CHRONIC DISEASE; HUMANS; INFLAMMATION; MACROPHAGES; MODELS, BIOLOGICAL; MULTIGENE FAMILY; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1; ORPHAN NUCLEAR RECEPTORS;

EID: 79953180610     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0390688     Document Type: Review

References (50)

1. Hasko, G. and Cronstein, B. N. (2004) Adenosine: an endogenous regulator of innate immunity. Trends Immunol. 25, 33-39
2. Gordon, S. (2003) Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-35
3. Bartok, B. and Firestein, G. S. (2010) Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol. Rev. 233, 233-255
4. Tak, P.P. and Bresnihan, B. (2000) The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis. Arthritis Rheum. 43, 2619-2633 (Pubitemid 32001727)
5. Koch, A.E. (1998) Review: angiogenesis: implications for rheumatoid arthritis. Arthritis Rheum. 41, 951-962
6. McInnes, I.B. and Schett, G. (2007) Cytokines in the pathogenesis of rheumatoid arthritis. Nat. Rev. Immunol. 7, 429-442
7. Brennan, F.M. and McInnes, I.B. (2008) Evidence that cytokines play a role in rheumatoid arthritis. J. Clin. Invest. 118, 3537-3545
8. Burrage, P.S., Mix, K.S. and Brinckerhoff, C.E. (2006) Matrix metalloproteinases: role in arthritis. Front. Biosci. 11, 529-543
9. Kaplan, M.J. (2006) Cardiovascular disease in rheumatoid arthritis. Curr. Opin. Rheumatol. 18, 289-297
10. Krueger, J.G. and Bowcock, A. (2005) Psoriasis pathophysiology: current concepts of pathogenesis. Ann. Rheum. Dis. 64 (Suppl. 2), ii30-ii36
11. Bata-Csorgo, Z., Hammerberg, C., Voorhees, J.J. and Cooper, K.D. (1995) Intralesional T-lymphocyte activation as a mediator of psoriatic epidermal hyperplasia. J. Invest. Dermatol. 105, 89S-94S
12. Wrone-Smith, T., Mitra, R.S., Thompson, C.B., Jasty, R., Castle, V.P. and Nickoloff, B.J. (1997) Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin. Am. J. Pathol. 151, 1321-1329
13. Kane, D., Gogarty, M., O'Leary, J., Silva, I., Bermingham, N., Bresnihan, B. and FitzGerald, O. (2004) Reduction of synovial sublining layer inflammation and proinflammatory cytokine expression in psoriatic arthritis treated with methotrexate. Arthritis Rheum. 50, 3286-3295 (Pubitemid 39372006)
14. Markham, T., Mullan, R., Golden-Mason, L., Rogers, S., Bresnihan, B., FitzGerald, O., Fearon, U. and Veale, D.J. (2006) Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy. J. Am. Acad. Dermatol. 54, 1003-1012
15. 2A adenosine receptor stimulation decreases foam cell formation by enhancing ABCA1-dependent cholesterol efflux. J. Leukocyte Biol. 87, 683-690
16. Bensinger, S.J. and Tontonoz, P. (2008) Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature 454, 470-477
17. Zelcer, N. and Tontonoz, P. (2006) Liver X receptors as integrators of metabolic and inflammatory signaling. J. Clin. Invest. 116, 607-614
18. Arkenbout, E.K., de Waard, V., van Bragt, M., van Achterberg, T.A., Grimbergen, J.M., Pichon, B., Pannekoek, H. and de Vries, C.J. (2002) Protective function of transcription factor TR3 orphan receptor in atherogenesis: decreased lesion formation in carotid artery ligation model in TR3 transgenic mice. Circulation 106, 1530-1535
19. 2 regulates the nuclear receptor NR4A2 in colorectal cancer. J. Biol. Chem. 281, 2676-2682
20. O'Kane, M., Markham, T., McEvoy, A.N., Fearon, U., Veale, D.J., FitzGerald, O., Kirby, B. and Murphy, E.P. (2008) Increased expression of the orphan nuclear receptor NURR1 in psoriasis and modulation following TNF-α inhibition. J. Invest. Dermatol. 128, 300-310
21. Bonta, P.I., van Tiel, C.M., Vos, M., Pols, T.W., van Thienen, J.V., Ferreira, V., Arkenbout, E.K., Seppen, J., Spek, C.A., Van Der Poll, T. et al. (2006) Nuclear receptors Nur77, Nurr1, and NOR-1 expressed in atherosclerotic lesion macrophages reduce lipid loading and inflammatory responses. Arterioscler. Thromb. Vasc. Biol. 26, 2288-2294
22. Zhao, Y. and Bruemmer, D. (2009) NR4A orphan nuclear receptors in cardiovascular biology. Drug Discovery Today Dis. Mech. 6, e43-e48
23. Doi, Y., Oki, S., Ozawa, T., Hohjoh, H., Miyake, S. and Yamamura, T. (2008) Orphan nuclear receptor NR4A2 expressed in T cells from multiple sclerosis mediates production of inflammatory cytokines. Proc. Natl. Acad. Sci. U.S.A. 105, 8381-8386
24. de Waard, V., Arkenbout, E.K., Vos, M., Mocking, A.I., Niessen, H.W., Stooker, W., de Mol, B.A., Quax, P.H., Bakker, E.N., VanBavel, E. et al. (2006) TR3 nuclear orphan receptor prevents cyclic stretch-induced proliferation of venous smooth muscle cells. Am. J. Pathol. 168, 2027-2035
25. Pei, L., Castrillo, A. and Tontonoz, P. (2006) Regulation of macrophage inflammatory gene expression by the orphan nuclear receptor Nur77. Mol. Endocrinol. 20, 786-794
26. Murphy, E.P., McEvoy, A., Conneely, O.M., Bresnihan, B. and FitzGerald, O. (2001) Involvement of the nuclear orphan receptor NURR1 in the regulation of corticotropin-releasing hormone expression and actions in human inflammatory arthritis. Arthritis Rheum. 44, 782-793 (Pubitemid 32319770)
27. Pei, L., Castrillo, A., Chen, M., Hoffmann, A. and Tontonoz, P. (2005) Induction of NR4A orphan nuclear receptor expression in macrophages in response to inflammatory stimuli. J. Biol. Chem. 280, 29256-29262
28. Aherne, C.M., McMorrow, J., Kane, D., FitzGerald, O., Mix, K.S. and Murphy, E.P. (2009) Identification of NR4A2 as a transcriptional activator of IL-8 expression in human inflammatory arthritis. Mol. Immunol. 46, 3345-3357
29. Ordentlich, P., Yan, Y., Zhou, S. and Heyman, R.A. (2003) Identification of the antineoplastic agent 6-mercaptopurine as an activator of the orphan nuclear hormone receptor Nurr1. J. Biol. Chem. 278, 24791-24799
30. 2A receptor-mediated responses. J. Immunol. 175, 555-565
31. Abu-Shakra, M., Gladman, D.D., Thorne, J.C., Long, J., Gough, J. and Farewell, V.T. (1995) Long-term methotrexate therapy in psoriatic arthritis: clinical and radiological outcome. J. Rheumatol. 22, 241-245
32. Weinblatt, M.E., Maier, A.L., Fraser, P.A. and Coblyn, J.S. (1998) Long-term prospective study of methotrexate in rheumatoid arthritis: conclusion after 132 months of therapy. J. Rheumatol. 25, 238-242 (Pubitemid 28088249)
33. Boyle, D.L., Sajjadi, F.G. and Firestein, G.S. (1996) Inhibition of synoviocyte collagenase gene expression by adenosine receptor stimulation. Arthritis Rheum. 39, 923-930 (Pubitemid 26182059)
34. Seitz, M., Zwicker, M. and Loetscher, P. (1998) Effects of methotrexate on differentiation of monocytes and production of cytokine inhibitors by monocytes. Arthritis Rheum. 41, 2032-2038 (Pubitemid 28506694)
35. Chan, E.S. and Cronstein, B.N. (2010) Methotrexate: how does it really work? Nat. Rev. Rheumatol. 6, 175-178
36. Desai, A., Victor-Vega, C., Gadangi, S., Montesinos, M.C., Chu, C.C. and Cronstein, B.N. (2005) Adenosine A2A receptor stimulation increases angiogenesis by down-regulating production of the antiangiogenic matrix protein thrombospondin 1. Mol. Pharmacol. 67, 1406-1413
37. 2A receptors. Am. J. Pathol. 160, 2009-2018
38. Montesinos, M.C., Desai, A., Delano, D., Chen, J.F., Fink, J.S., Jacobson, M.A. and Cronstein, B.N. (2003) Adenosine A2A or A3 receptors are required for inhibition of inflammation by methotrexate and its analog MX-68. Arthritis Rheum. 48, 240-247 (Pubitemid 36091669)
39. 2A receptor activation promotes wound neovascularization by stimulating angiogenesis and vasculogenesis. Am. J. Pathol. 164, 1887-1892
40. Feldmann, M. and Maini, S.R. (2008) Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics. Immunol. Rev. 223, 7-19
41. Zintzaras, E., Dahabreh, I.J., Giannouli, S., Voulgarelis, M. and Moutsopoulos, H.M. (2008) Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens. Clin. Ther. 30, 1939-1955
42. Helliwell, P.S. and Taylor, W.J. (2008) Treatment of psoriatic arthritis and rheumatoid arthritis with disease modifying drugs: comparison of drugs and adverse reactions. J. Rheumatol. 35, 472-476 (Pubitemid 351374424)
43. Mix, K.S., Attur, M.G., Al-Mussawir, H., Abramson, S.B., Brinckerhoff, C.E. and Murphy, E.P. (2007) Transcriptional repression of matrix metalloproteinase gene expression by the orphan nuclear receptor NURR1 in cartilage. J. Biol. Chem. 282, 9492-9504
44. Hamilton, J.A. and Tak, P.P. (2009) The dynamics of macrophage lineage populations in inflammatory and autoimmune diseases. Arthritis Rheum. 60, 1210-1221
45. Bonta, P.I., Pols, T.W., van Tiel, C.M., Vos, M., Arkenbout, E.K., Rohlena, J., Koch, K.T., de Maat, M.P., Tanck, M.W., de Winter, R.J. et al. (2010) Nuclear receptor Nurr1 is expressed in and is associated with human restenosis and inhibits vascular lesion formation in mice involving inhibition of smooth muscle cell proliferation and inflammation. Circulation 121, 2023-2032
46. Saijo, K., Winner, B., Carson, C.T., Collier, J.G., Boyer, L., Rosenfeld, M.G., Gage, F.H. and Glass, C.K. (2009) A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 137, 47-59
47. Gordon, S. and Taylor, P.R. (2005) Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5, 953-964
48. Mantovani, A., Sozzani, S., Locati, M., Allavena, P. and Sica, A. (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23, 549-555 (Pubitemid 35223554)
49. Hamilton, J.A. (2002) GM-CSF in inflammation and autoimmunity. Trends Immunol. 23, 403-408
50. Liew, F.Y., Pitman, N.I. and McInnes, I.B. (2010) Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat. Rev. Immunol. 10, 103-110